High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
Abstract 27-hydroxycholesterol (27HC), synthesized from cholesterol by the enzyme CYP27A1, differentially impacts estrogen receptor positive (ER+) breast cancer (BC) cell growth depending on estrogen levels. This study examined the association between CYP27A1 expression and prognosis in a cohort of...
Main Authors: | Maria Inasu, Pär-Ola Bendahl, Mårten Fernö, Per Malmström, Signe Borgquist, Siker Kimbung |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-09-01
|
Series: | npj Breast Cancer |
Online Access: | https://doi.org/10.1038/s41523-021-00333-6 |
Similar Items
-
Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status.
by: Jon Lidfeldt, et al.
Published: (2015-01-01) -
Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit
by: Terese Engström, et al.
Published: (2024-04-01) -
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
by: Christine Lundgren, et al.
Published: (2022-05-01) -
Tamoxifen-predictive value of gene expression signatures in premenopausal breast cancer: data from the randomized SBII:2 trial
by: Christine Lundgren, et al.
Published: (2023-09-01) -
Co-localization of CD169+ macrophages and cancer cells in lymph node metastases of breast cancer patients is linked to improved prognosis and PDL1 expression
by: Frida Björk Gunnarsdottir, et al.
Published: (2020-01-01)